Objective To evaluate the safety and effectiveness of the Flow Redirection Endoluminal Device (FRED) flow diverter in support of an application for Food and Drug Administration approval in the USA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback